Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
Description
Herein, we describe three patients affected by metastatic colorectal cancer (mCRC) experiencing infection by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and reduction of disease burden during coronavirus disease 2019 (COVID-19)
